389 related articles for article (PubMed ID: 16455626)
1. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
[TBL] [Abstract][Full Text] [Related]
2. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
[TBL] [Abstract][Full Text] [Related]
4. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
[TBL] [Abstract][Full Text] [Related]
5. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
7. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
[TBL] [Abstract][Full Text] [Related]
8. Correction of partial volume effect in (18)F-FDG PET brain studies using coregistered MR volumes: voxel based analysis of tracer uptake in the white matter.
Coello C; Willoch F; Selnes P; Gjerstad L; Fladby T; Skretting A
Neuroimage; 2013 May; 72():183-92. PubMed ID: 23370062
[TBL] [Abstract][Full Text] [Related]
9. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain.
Mascalchi M; Lolli F; Della Nave R; Tessa C; Petralli R; Gavazzi C; Politi LS; Macucci M; Filippi M; Piacentini S
Radiology; 2004 Sep; 232(3):867-73. PubMed ID: 15215553
[TBL] [Abstract][Full Text] [Related]
10. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of gray- and white-matter volumes and glucose metabolism in Sturge-Weber syndrome.
Pfund Z; Kagawa K; Juhász C; Shen C; Lee JS; Chugani DC; Muzik O; Chugani HT
J Child Neurol; 2003 Feb; 18(2):119-26. PubMed ID: 12693779
[TBL] [Abstract][Full Text] [Related]
12. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
13. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
14. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
15. Brain structure in preclinical Huntington's disease.
Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
[TBL] [Abstract][Full Text] [Related]
18. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.
Squitieri F; Cannella M; Simonelli M; Sassone J; Martino T; Venditti E; Ciammola A; Colonnese C; Frati L; Ciarmiello A
CNS Neurosci Ther; 2009; 15(1):1-11. PubMed ID: 19228174
[TBL] [Abstract][Full Text] [Related]
19. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
